Secondary care safety information

Information for hospital staff

Advice for secondary clinicians regarding caring for trial participants

If you are caring for a patient enrolled in the PRINCIPLE trial who is taking a study medication, please be aware that 

• They should only continue the study medication if you judge it is clinically safe to do so: treatment decisions, including study medications, remain the responsibility of the clinical team.
• We will continue to follow up PRINCIPLE trial participants until 28 days after trial entry.
• We are working in partnership with RECOVERY and RECOVERY-RS Trials.
  Details regarding the possibility of recruitment into these trials can be found here.

Training Slides

Signposting for secondary care

Posters

• PRINCIPLE Patient Recruitment Poster

Text, email and social media

• Social Media Template
• Text Message Template
• Email Template
• Website Advert Template
• Introductory Letter
• Patient Recruitment Letter

Newsletters

• Newsletter June 2020

Documents for secondary and ambulatory care

• Protocol 
• Patient information Sheet
• Pictorial Patient Information Sheet
• Alternative Language PIS forms are located here.

Information for 111 Hubs